Annual report [Section 13 and 15(d), not S-K Item 405]

Net Loss per Share Attributable to Common Stock - Schedule of Outstanding Shares of Common Stock Equivalents (Details)

v3.26.1
Net Loss per Share Attributable to Common Stock - Schedule of Outstanding Shares of Common Stock Equivalents (Details) - shares
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 43,996 147,707
Non-vested restricted stock awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 134,581 546,653
Non-vested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 2,048,090 3,018,374
Common stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 0 240,100